MADRIGAL PHARMACEUTICALS, INC. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- MADRIGAL PHARMACEUTICALS, INC. stock issued during period, value, stock options exercised for the quarter ending 2021-09-30 was $8.00K, a 97.71% decline year-over-year.
- MADRIGAL PHARMACEUTICALS, INC. stock issued during period, value, stock options exercised for the quarter ending 2021-03-31 was $478.00K.
- MADRIGAL PHARMACEUTICALS, INC. stock issued during period, value, stock options exercised for the quarter ending 2020-09-30 was $350.00K, a 900.00% increase year-over-year.
- MADRIGAL PHARMACEUTICALS, INC. stock issued during period, value, stock options exercised for the quarter ending 2020-06-30 was $109.00K, a 6.84% decline year-over-year.
- MADRIGAL PHARMACEUTICALS, INC. stock issued during period, value, stock options exercised for fiscal 2014 was $854.00K, a 22.78% decline from fiscal 2013.
- MADRIGAL PHARMACEUTICALS, INC. stock issued during period, value, stock options exercised for fiscal 2013 was $1.11M, a 3.07% decline from fiscal 2012.
- MADRIGAL PHARMACEUTICALS, INC. stock issued during period, value, stock options exercised for fiscal 2012 was $1.14M, a 138.20% increase from fiscal 2011.
- MADRIGAL PHARMACEUTICALS, INC. stock issued during period, value, stock options exercised for fiscal 2011 was $479.00K, a 51.58% increase from fiscal 2010.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2021-09-30 | $8.00K 10-Q · filed 2021-11-04 | |
| 2021-03-31 | $478.00K 10-Q · filed 2021-11-04 | |
| 2020-09-30 | $350.00K 10-Q · filed 2021-11-04 | |
| 2020-06-30 | $109.00K 10-Q · filed 2021-11-04 | |
| 2019-09-30 | $35.00K 10-Q · filed 2020-11-05 | |
| 2019-06-30 | $117.00K 10-Q · filed 2020-11-05 | |
| 2019-03-31 | $83.00K 10-Q · filed 2020-11-05 | |
| 2018-09-30 | $451.00K 10-Q · filed 2019-11-06 | |
| 2018-06-30 | $1.19M 10-Q · filed 2019-11-06 | |
| 2018-03-31 | $265.00K 10-Q · filed 2019-11-06 | |
| 2014-12-31 | $854.00K 10-K · filed 2016-03-15 | |
| 2013-12-31 | $1.11M 10-K · filed 2016-03-15 | |
| 2012-12-31 | $1.14M 10-K · filed 2015-03-12 | |
| 2011-12-31 | $479.00K 10-K · filed 2014-03-11 | |
| 2010-12-31 | $316.00K 10-K · filed 2013-03-14 | |
| 2009-12-31 | $50.00K 10-K · filed 2012-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |